Top brand choice
Strength | Pack Size | Qty | |
---|---|---|---|
Strength
55mcg (62.5mcg) (30 doses/inhaler)
|
We guarantee the lowest price on all of our prescription products. If you find your medications cheaper at any other recognized licensed mail order pharmacy, we will not only match their price, we will beat it by 25% of the difference. It is our 125% price match guarantee!
Example: If you find a product on Canada Drugs Direct for $50.00 and find the same product for $40.00 at another mail order pharmacy, we will provide you with a $12.50 discount, bringing your total to $37.50.
To get the discount please make sure to mention the price match to the customer service team when they call to collect payment for your order. Or call toll free at 1-888-904-8467 to place the order through the phone.
Terms & Conditions of Program
A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
Incruse Ellipta is a prescription inhaler product that is used to treat the symptoms of Chronic Obstructive Pulmonary Disease (COPD). Symptoms of COPD may include coughing, breathing difficulty, and wheezing.
COPD is a group of diseases that includes emphysema and chronic bronchitis. These conditions are long-term and tend to get worse over time. Maintenance medications like Incruse Ellipta may decrease the severity and number of acute episodes.
Fact Table | |
Formula |
C29H34BrNO2 |
License |
EU EMA |
Bioavailability |
13% |
Legal status |
Rx-only |
Chemical Name |
Umeclidinium |
Elimination half-life |
11 hours |
Dosage (Strength) |
55mcg |
Pregnancy |
Consult Doctor |
Brands |
Incruse Ellipta |
Protein binding |
~89% |
PubChem CID |
11519069 |
MedlinePlus |
a614024 |
ChEBI |
79040 |
ATC code |
R03BB07 |
DrugBank |
DB09076 |
KEGG |
D10181 |
Routes of administration |
Inhalation |
The standard dosage of Incruse Ellipta is one inhalation by mouth once daily. Take it every day to achieve the full effect of the medication. It should not be used for acute symptoms.
The active ingredient in the Incruse Ellipta inhaler is umeclidinium.
Umeclidinium is an anticholinergic medication that affects the smooth muscles of the lungs. When the drug enters the airways, it causes their relaxation, which makes it easier to breathe.
Before you start Incruse Ellipta, tell your healthcare team if you are taking any of the following:
Tell your doctor if you have a history of narrow-angle glaucoma or urinary retention before starting this drug.
Do not use this inhaler for acute symptoms and breathing problems.
Do not use this medication if you have a known allergy to milk or milk products.
The most common Incruse Ellipta side effects may include: